PCVX
Vaxcyte, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -8.3% ·
Aktienfluss +8.1% ·
neue Nettopositionen -9.1%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +1 | 85.77M | $4.99B | +6 | −4 |
| Q1 2026 | 115 | +4 | 93.55M | $5.43B | +8 | −5 |
| Q4 2025 | 111 | 0 | 92.90M | $4.29B | +2 | −1 |
| Q3 2025 | 18 | +2 | 60.74M | $2.19B | +3 | −2 |
| Q2 2025 | 14 | 0 | 57.50M | $1.87B | +1 | −1 |
| Q1 2025 | 11 | -1 | 19.96M | $753.77M | — | −1 |
| Q4 2024 | 12 | +1 | 18.46M | $1.51B | +1 | — |
| Q3 2024 | 10 | +2 | 13.93M | $1.59B | +3 | −1 |
| Q2 2024 | 8 | — | 11.72M | $885.19M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passiv) | 4.41M | -2.9% | $166.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.54M | -10.7% | $133.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 3.54M | -10.7% | $133.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 2.87M | +2.4% | $108.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passiv) | 2.87M | +2.4% | $108.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Norges Bank ✦ (passiv) | 899.84K | -18.2% | $33.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 867.89K | +11.9% | $32.77M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Millennium Management ✦ | 413.43K | +49.5% | $15.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 245.32K | -2.3% | $9.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 196.28K | +263.0% | $7.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 96.39K | -32.0% | $3.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Duquesne Family Office | $7.06M | war 0.2% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 53.30K Anteile, $3,097 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.